tiprankstipranks
National Health Investors (CH:WX6)
NYSE:WX6
Switzerland Market
WX6
National Health Investors
RESEARCH TOOLSreports

National Health Investors (WX6) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

WX6 Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
4 Buy
2 Hold
0 Sell
Based on 6 analysts giving stock ratings to
National
Health Investors
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WX6 Stock 12 Month Forecast

Average Price Target

$69.39
Based on 6 Wall Street analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $69.39 with a high forecast of $76.00 and a low forecast of $64.68. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$76.00Average Price Target$69.39Lowest Price Target$64.68
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:WX6
John Kilichowski
Wells Fargo
Wells Fargo
CHF56.59→CHF71.95
Hold
―
Assigned
07/15/26
Wells Fargo Remains a Hold on National Health Investors (NHI)
Deutsche Bank Analyst forecast on CH:WX6
Omotayo Okusanya
Deutsche Bank
Deutsche Bank
CHF68.72→CHF64.68
Hold
―
Reiterated
06/25/26
National Health Investors price target lowered to $80 from $85 at Deutsche BankNational Health Investors price target lowered to $80 from $85 at Deutsche Bank
BMO Capital Analyst forecast on CH:WX6
Juan C. Sanabria
BMO Capital
BMO Capital
CHF72.76→CHF64.68
Buy
―
Reiterated
06/15/26
National Health Investors price target lowered to $80 from $90 at BMO CapitalNational Health Investors price target lowered to $80 from $90 at BMO Capital
Truist Financial Analyst forecast on CH:WX6
Michael Lewis
Truist Financial
Truist Financial
CHF71.95→CHF65.49
Buy
―
Reiterated
06/12/26
Analysts Offer Insights on Real Estate Companies: National Health Investors (NYSE: NHI), RLJ Lodging (NYSE: RLJ) and Regency Centers (NASDAQ: REG)
Bank of America Securities Analyst forecast on CH:WX6
Farrell Granath
Bank of America Securities
Bank of America Securities
CHF73.57
Buy
―
Reiterated
06/10/26
Bank of America Securities Remains a Buy on National Health Investors (NHI)
Cantor Fitzgerald Analyst forecast on CH:WX6
Richard Anderson
Cantor Fitzgerald
Cantor Fitzgerald
CHF76
Buy
―
Reiterated
04/22/26
Analysts Offer Insights on Real Estate Companies: Ryman (NYSE: RHP), National Health Investors (NYSE: NHI) and Camden Property (NYSE: CPT)
Jefferies Analyst forecast on CH:WX6
Unknown Analyst
Jefferies
Not Ranked
Jefferies
CHF62.25
Hold
―
Reiterated
12/15/25
National Health Investors (NHI) Gets a Hold from Jefferies
KeyBanc Analyst forecast on CH:WX6
Austin Wurschmidt
KeyBanc
KeyBanc
CHF64.68→CHF71.15
Buy
―
Reiterated
12/04/25
KeyBanc Sticks to Its Buy Rating for National Health Investors (NHI)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:WX6
John Kilichowski
Wells Fargo
Wells Fargo
CHF56.59→CHF71.95
Hold
―
Assigned
07/15/26
Wells Fargo Remains a Hold on National Health Investors (NHI)
Deutsche Bank Analyst forecast on CH:WX6
Omotayo Okusanya
Deutsche Bank
Deutsche Bank
CHF68.72→CHF64.68
Hold
―
Reiterated
06/25/26
National Health Investors price target lowered to $80 from $85 at Deutsche BankNational Health Investors price target lowered to $80 from $85 at Deutsche Bank
BMO Capital Analyst forecast on CH:WX6
Juan C. Sanabria
BMO Capital
BMO Capital
CHF72.76→CHF64.68
Buy
―
Reiterated
06/15/26
National Health Investors price target lowered to $80 from $90 at BMO CapitalNational Health Investors price target lowered to $80 from $90 at BMO Capital
Truist Financial Analyst forecast on CH:WX6
Michael Lewis
Truist Financial
Truist Financial
CHF71.95→CHF65.49
Buy
―
Reiterated
06/12/26
Analysts Offer Insights on Real Estate Companies: National Health Investors (NYSE: NHI), RLJ Lodging (NYSE: RLJ) and Regency Centers (NASDAQ: REG)
Bank of America Securities Analyst forecast on CH:WX6
Farrell Granath
Bank of America Securities
Bank of America Securities
CHF73.57
Buy
―
Reiterated
06/10/26
Bank of America Securities Remains a Buy on National Health Investors (NHI)
Cantor Fitzgerald Analyst forecast on CH:WX6
Richard Anderson
Cantor Fitzgerald
Cantor Fitzgerald
CHF76
Buy
―
Reiterated
04/22/26
Analysts Offer Insights on Real Estate Companies: Ryman (NYSE: RHP), National Health Investors (NYSE: NHI) and Camden Property (NYSE: CPT)
Jefferies Analyst forecast on CH:WX6
Unknown Analyst
Jefferies
Not Ranked
Jefferies
CHF62.25
Hold
―
Reiterated
12/15/25
National Health Investors (NHI) Gets a Hold from Jefferies
KeyBanc Analyst forecast on CH:WX6
Austin Wurschmidt
KeyBanc
KeyBanc
CHF64.68→CHF71.15
Buy
―
Reiterated
12/04/25
KeyBanc Sticks to Its Buy Rating for National Health Investors (NHI)
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
RHPRyman
IRMIron Mountain
RITMRithm Capital
AHRAmerican Healthcare REIT, Inc.
BEKEKE Holdings Inc. Sponsored ADR Class A
Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering National Health Investors

3 Months
Richard AndersonCantor Fitzgerald
Success Rate
4/5 ratings generated profit
80%
Average Return
+6.78%
Copying Richard Anderson's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +6.78% per trade.
1 Year
Juan C. SanabriaBMO Capital
Success Rate
15/18 ratings generated profit
83%
Average Return
+9.70%
Copying Juan C. Sanabria's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +9.70% per trade.
2 Years
Juan C. SanabriaBMO Capital
Success Rate
15/18 ratings generated profit
83%
Average Return
+11.44%
Copying Juan C. Sanabria's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +11.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WX6 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
5
7
7
9
6
Hold
2
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
9
9
11
8
In the current month, WX6 has received 6 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. WX6 average Analyst price target in the past 3 months is 69.39.
Each month's total comprises the sum of three months' worth of ratings.

WX6 Financial Forecast

WX6 Earnings Forecast

Next quarter’s earnings estimate for WX6 is $0.68 with a range of $0.62 to $0.74. The previous quarter’s EPS was $0.66. WX6 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year WX6 has Performed in-line its overall industry.
Next quarter’s earnings estimate for WX6 is $0.68 with a range of $0.62 to $0.74. The previous quarter’s EPS was $0.66. WX6 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year WX6 has Performed in-line its overall industry.

WX6 Sales Forecast

Next quarter’s sales forecast for WX6 is $58.56M with a range of $58.17M to $58.96M. The previous quarter’s sales results were $93.67M. WX6 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year WX6 has Performed in-line its overall industry.
Next quarter’s sales forecast for WX6 is $58.56M with a range of $58.17M to $58.96M. The previous quarter’s sales results were $93.67M. WX6 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year WX6 has Performed in-line its overall industry.

WX6 Stock Forecast FAQ

What is CH:WX6’s average 12-month price target, according to analysts?
Based on analyst ratings, National Health Investors’s 12-month average price target is 69.39.
    What is CH:WX6’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:WX6, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is National Health Investors a Buy, Sell or Hold?
        National Health Investors has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
          What is National Health Investors’s share price target?
          The average share price target for National Health Investors is 69.39. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $76.00 ,and the lowest forecast is $64.68. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about National Health Investors?
            National Health Investors’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
              How can I buy shares of National Health Investors?
              To buy shares of CH:WX6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.